Lines blurring between human herpes simplex viruses

The line between the human herpes simplex viruses—HSV-1 and HSV-2—is blurrier than previously thought, according to a new study published this week in the Journal of Infectious Diseases. Researchers found that HSV-1 and HSV-2 are mixing together to result in several new, different recombinant versions of herpes. “The main implication is that HSV-1 and HSV-2 are continuing to recombine,” said […]

Continue reading »

Robust immune responses for herpes zoster subunit vaccine

(HealthDay)—Recipients of the herpes zoster subunit vaccine (HZ/su), consisting of varicella-zoster virus glycoprotein E (gE) and AS01B Adjuvant System, develop robust immune responses, according to a study published in the June 1 issue of The Journal of Infectious Diseases. Anthony L. Cunningham, M.D., from the University of Sydney, and colleagues presented immunogenicity results from two trials involving patients aged 50 […]

Continue reading »